Show simple item record

dc.contributor.advisorHusebekk, Anne
dc.contributor.advisorWikmann, Agneta Taune
dc.contributor.authorRefsum, Erle
dc.date.accessioned2016-12-13T08:27:52Z
dc.date.available2016-12-13T08:27:52Z
dc.date.issued2012-06-01
dc.description.abstractBackground: Foetal and neonatal alloimmune thrombocytopenia (FNAIT) is estimated to occur at an incidence of 1:1-2000 live borns, while maternal immunisation against HLA class I is a common finding during pregnancy and after delivery. Whether anti-HLA antibodies can cause FNAIT in some cases is debateable. Aim: This study aims to give a background to FNAIT, and to describe cases of suspected or anticipated FNAIT referred to the thrombocyte and leukocyte laboratory at Karolinska University Hospital, with a focus on cases that could be due to anti-HLA class I antibodies. In an experimental part, anti-HLA class I antibody specificities in selected cases were analysed and the expression of HLA class I antigens on adult and umbilical cord blood platelets was determined. Results: Out of 260 patients referred from January 2007 until March 2012, alloantibodies were detected in 43%, and anti-HLA class I antibodies were most common. 35 patients were diagnosed with FNAIT with HPA incompatibilities between the parents and detectable antibodies. Sera from 23 anti-HLA class I immunised mothers were analysed further, and most of them had antibodies reactive with several specificities. The most common specificities were of the HLA-B type, against rare alleles. Flow cytometry analysis of HLA-A,B,C and HLA-B,C on platelets indicated that platelets from neonates had a higher HLA-A expression and lower HLA-BC expression. Conclusion: FNAIT is rare, and is probably even more rarely caused by HLA class I immunisation, although it remains a possibility. Maternal anti-HLA class I antibodies have been shown to be associated with complications related to pregnancy, and it is not clear how the presence of these antibodies affects the foetus. In cases of suspected HLA alloimmunisation, most of the mothers had broadly reacting antibodies. The expression of HLA class I on platelets seems to be different in adult and umbilical cord blood.en_US
dc.identifier.urihttps://hdl.handle.net/10037/10023
dc.language.isoengen_US
dc.publisherUniversitetet i Tromsøen_US
dc.publisherUniversity of Tromsøen_US
dc.rights.accessRightsopenAccessen_US
dc.rights.holderCopyright 2012 The Author(s)
dc.rights.urihttps://creativecommons.org/licenses/by-nc-sa/3.0en_US
dc.rightsAttribution-NonCommercial-ShareAlike 3.0 Unported (CC BY-NC-SA 3.0)en_US
dc.subject.courseID5.-årsoppgaveen_US
dc.subjectVDP::Medical disciplines: 700::Basic medical, dental and veterinary science disciplines: 710::Medical immunology: 716en_US
dc.subjectVDP::Medisinske Fag: 700::Basale medisinske, odontologiske og veterinærmedisinske fag: 710::Medisinsk immunologi: 716en_US
dc.titleFoetal and neonatal alloimmune thrombocytopenia and HLA class I alloimmunisationsen_US
dc.typeMaster thesisen_US
dc.typeMastergradsoppgaveen_US


File(s) in this item

Thumbnail
Thumbnail

This item appears in the following collection(s)

Show simple item record

Attribution-NonCommercial-ShareAlike 3.0 Unported (CC BY-NC-SA 3.0)
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-ShareAlike 3.0 Unported (CC BY-NC-SA 3.0)